Atlas Trials

An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.

Clinical trial NCT07182214 · RECRUITING

Trial details

NCT number
NCT07182214
Sponsor
Pharus Taiwan, Inc.
Status
RECRUITING
Study type
OBSERVATIONAL
Lung Cancer
Start date
2024-05-05
Primary completion
2026-06-30
Enrollment
1340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.